9999999997-14-007099.txt : 20140411 9999999997-14-007099.hdr.sgml : 20140411 20140411120412 ACCESSION NUMBER: 9999999997-14-007099 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140411 DATE AS OF CHANGE: 20140411 20140411 20140411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 14759150 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C$P(#`@;V)J#3P\+TQI;F5A7!E+UA2968O5ULQ(#(@,5T^/G-T#0IE;F1S M=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@("`@#0HR M,B`P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22`X-"],(#8X+TQE;F=T M:"`V,2]3(#,X/CYS=')E86T-"FC>8F!@8&9@8.)G``*.]0RH@!&(61@X&I#% MF*&8@:&1@9N!0VD23*7H"ZB.-K`N!M5@")^1%2#``,$K!*\-"F5N9'-T7!E+T-A=&%L;V<^/@UE;F1O8FH-,3(@ M,"!O8FH-/#PO0V]N=&5N=',@,30@,"!2+T-R;W!";WA;,"`P(#8Q,B`W.3)= M+TUE9&EA0F]X6S`@,"`V,3(@-SDR72]087)E;G0@."`P(%(O4F5S;W5R8V5S M(#$V(#`@4B]2;W1A=&4@,"]4>7!E+U!A9V4^/@UE;F1O8FH-,3,@,"!O8FH- M/#PO1FEL=&5R+T9L871E1&5C;V1E+T9IR M>N=Q5SMN5Z:RD`P%N]2[SR;?;"WRY)Q=&0\-I(C9M-";%H+0,9Q,ZOUB$$4) M#`*N<#Z.@W,9+QTZU65>/'[(\M*T<&M^PUU=ZNJCPVYU:9A#$'#Q>3J8U,5Z MECD\M8VQJRV[K9M2%RYT[RDI9/3%ZB)?C:M-88"SU)KR.W[GV,]'N42YR7>V M;MB/HU';5A]WDUKMK\Z7V:-ZV]W.H&`GER"ETT7=)7 MW64(B;P>?EHBE#4/QC%[HH>MUW;;+F3$@5;$O3U>A`5!`#Z',L[MESLH*;LG M[3A6$`L!2B5N!\G095%\&(8^#^.4XZNB*'9HWZ'O>%C^3/\,L0=5D'51]*5* M_"1H$YR$8HYS%'<5Q"+HD*[7\KUBC)^+D:NWB?%5'89G=)C(]\GPK0J4_$2! M8?P?"CPLN@_:_];@N;?^SH]5Z+37*8GTU=^V.PD5X'65=%ZO/:]-[QTT^/=R MRN//K=/4"2/9*?_T[^E9R"/,<>`O_Y>O+>R'&OXCP``,D)-P#0IE;F1S=')E M86T-96YD;V)J#3$T(#`@;V)J#3P\+T9I;'1EJL+BB+I:U;UY?LM[= M.$6L+0HT12';=,Q"EKP2ET M]R%-?6"0;GO,!P]_\95X$'M#.@PAW?<\>,2_=*T>SST"3OI/CPW!991%D$[L M2OJK';@!39+C5Y=Z'DN4N1T\]_XDWQ?S=.JX(4W(!):.&]&8I`YE9)2:U:E= M!.>O]$O/'=`XCLXQO8'%5`.%N9R.O]_/T[F#NT,$@-%B`GA(0`?DC_'GT>+& M3F!\=WL[7R[G=PL#']-3<`49*&S7CC#FT:$2.3#6!]]CH0F3H9_#$[M+BB*: M#"Y<;FGP+`UW]Y/I/=PX[A!#OQ\MTOGB!KU;S+1;S*=AB/EHK7UK'?G&>CZ9 MHL7H&Z3WTU%ZBQ/+%AH.HHN(_)9X=6+Z>0HM74C4U-(#HW$*=S-@2:#8]TEH M`3$3X3N1)C1AU\>M.Z_5P;_S2O(7^&V75?MLS1LIUEE>P[Q8E]6AK#)'G2<= M!!D2OC'G#JGW'L'HUC")_H?BF5!)9R0W+^ZX/KY@45+P7#5)"-.'A3H([Z?E ME00LT0:J@$R"@G,3+*+.P5\"+X@&QDU,[E48Y.^W?O1^U&-H]*@2:2LS/`K- M.V&-"(GK*M/$>FXEWSC',7&T-_`AJ4.B+I4 M1N:`NEDIQ(`(B9:0%9`=#CDB2U$B3D0*:(H-K^"^R3GXX**`L7&F_+ MK1-B/X!UZ:B^4)BIV/!""E-U.TN'X;,"49S-S585 M=`%"MA%J;]Z3`N$OZ[S9('';JMR#W'&8ONS$2L@:9&E"\E7"O8N:SV!65GL8 MNE]A*W*TQW._-/DKRE6U)2^DMB]IZ^ON?.8+L[($K.@X8N135AO$BB/'-9*C M`]/\U+!ZA4Z_;8U$_I%TUL*&EG13)/0&34>I#F$W!CR;+Q5;P&K(:DUUL;8ISG.SWW+B-G9X=*SONV(@- M:+56^\L*"2ZR0D_T.>I*"8B5D3[-%+A*7I=W1#[S.&H;B-7EK.)\4QKEJ&J> MMQ$$%G.TEGV(X#M=TC&%*/(?R.K!>2"A\3VA7G3:H#I\+4ORX/2U/Q/Q)%K! MC$N5^R'UPV/07:X\JS?=`93!3`?-88<$ZDKR8^HGT1M1G7:##9?4A)AV;OC*V#G1UECH\\+Y]5*^(O*(6$:)W" ML\ASC%.O2%AQ%`TVAICD/*MQ$6^9C?ZF]:R#'V`*HI_G0+EG"`,,07LKQ1[7 M>"7*#=0'OE:EO?EH%6[@?GHQ6K&'W/. M?EF43UQQYY.5HSICU5KT[0#_#QJ8X,Q]%&I/]'UU=`8N+RQS]YTZ>4%%VY$\ M,K-$C%&]3HQLBEJ5=5\UHXLZ;UM2PMXH$:-MO+/+JTKO(^E5W:B;Q'9>UZ"< ME<=ELC8\YX^Z;66-W)65D*\?VXC>R,3UH"5))T3]?%64^OK>\>,0_^TF3X9D MH>8QS@LSM]S?JF5U^="SY;L6YE\-0Q97L!U>;CZ=#$PNT;O.J\F5^<&S[Q8JA<[-5NW@TI]"HX?.H3L=$=H$:.C3R=E,TU[_PDP`(AH'^,-"F5N M9'-T M,E,P4#!7,+10L+'1]RO-+8X&<0T4@F+M[(`BP?HN=G8``08`C84(-PT*96YD MFMC.60B/SX*/'@Z>&UP;65T M82!X;6QN#IX;7!T:STB061O8F4@6$U0 M($-O&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(CX*("`@ M("`@("`@/'!D9CI0&UP34TZ26YS=&%N8V5) M1#YU=6ED.CDQ9&$T-C-D+3$Q830M-&$U-RTY-&$U+35A86)F83-F.6-A,SPO M>&UP34TZ26YS=&%N8V5)1#X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@ M(#POJ'5!:DZ@S1<%K+O6`KM'-P,A;V$4BBA>-9[ M_7\RD-?;8HBU"_G['*&S(5KG#(%$(44%$QOMJOTG3)QG5QN=8;W=Y>`?$49/ M&E+(,2\/8F=#O&F^`@P`O`X^^`T*96YD7!E M+UA2968O5ULQ(#(@,5T^/G-T